These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15460175)

  • 1. Extended-release divalproex sodium for mood stabilization.
    Stoner SC; Dubisar BM; Lea JW; Marken PA; Ramlatchman LV; Reynolds JB
    Pharmacotherapy; 2004 Sep; 24(9):1147-53. PubMed ID: 15460175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodium.
    Horne RL; Cunanan C
    J Clin Psychopharmacol; 2003 Apr; 23(2):176-81. PubMed ID: 12640219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of patient preference and side effects in patients switched from divalproex sodium delayed release to divalproex sodium extended release.
    Minirth FB; Neal V
    J Clin Psychopharmacol; 2005 Feb; 25(1):99-101. PubMed ID: 15643111
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the safety, efficacy, and tolerability of switching from the standard delayed release preparation of divalproex sodium to the extended release formulation in patients with schizophrenia.
    Citrome L; Tremeau F; Wynn PS; Roy B; Dinakar H
    J Clin Psychopharmacol; 2004 Jun; 24(3):255-9. PubMed ID: 15118478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study.
    Apostol G; Lewis DW; Laforet GA; Robieson WZ; Fugate JM; Abi-Saab WM; Saltarelli MD
    Headache; 2009 Jan; 49(1):45-53. PubMed ID: 19040679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder.
    Redden L; DelBello M; Wagner KD; Wilens TE; Malhotra S; Wozniak P; Vigna NV; Greco N; Kovacs X; Abi-Saab W; Saltarelli M;
    J Child Adolesc Psychopharmacol; 2009 Feb; 19(1):83-9. PubMed ID: 19232026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
    Hirschfeld RM; Bowden CL; Vigna NV; Wozniak P; Collins M
    J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents.
    Apostol G; Pakalnis A; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
    Headache; 2009 Jan; 49(1):36-44. PubMed ID: 19040678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-release divalproex sodium for patients with side effects from delayed-release divalproex sodium.
    Longo LP
    Am J Psychiatry; 2005 Aug; 162(8):1548-9. PubMed ID: 16055790
    [No Abstract]   [Full Text] [Related]  

  • 10. Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders.
    Centorrino F; Kelleher JP; Berry JM; Salvatore P; Eakin M; Fogarty KV; Fellman V; Baldessarini RJ
    Am J Psychiatry; 2003 Jul; 160(7):1348-50. PubMed ID: 12832255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of divalproex sodium extended release containing regimen in Indian patients with bipolar I disorder in continuation phase: Results of EASED registry.
    Shah N; Reddy MS; Vohra S; Chaudhuri U; Mohanasundaram S
    Asian J Psychiatr; 2016 Apr; 20():32-8. PubMed ID: 27025469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).
    Suppes T; Vieta E; Liu S; Brecher M; Paulsson B;
    Am J Psychiatry; 2009 Apr; 166(4):476-88. PubMed ID: 19289454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of divalproex extended release in psychiatric patients.
    Jackson RS; Venkataraman S; Atkins RB; Owens M
    Ann Clin Psychiatry; 2006; 18(4):273-4. PubMed ID: 17162629
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical comparison of extended-release divalproex versus delayed-release divalproex: pooled data analyses from nine trials.
    Smith MC; Centorrino F; Welge JA; Collins MA
    Epilepsy Behav; 2004 Oct; 5(5):746-51. PubMed ID: 15380129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizure control and side-effect profile after switching adult epileptic patients from standard to extended-release divalproex sodium.
    Pierre-Louis SJ; Brannegan RT; Evans AT
    Clin Neurol Neurosurg; 2009 Jun; 111(5):437-41. PubMed ID: 19181439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.
    Freitag FG; Collins SD; Carlson HA; Goldstein J; Saper J; Silberstein S; Mathew N; Winner PK; Deaton R; Sommerville K;
    Neurology; 2002 Jun; 58(11):1652-9. PubMed ID: 12058094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid oral loading of extended release divalproex in patients with acute mania.
    Miller BP; Perry W; Moutier CY; Robinson SK; Feifel D
    Gen Hosp Psychiatry; 2005; 27(3):218-21. PubMed ID: 15882770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of oral loading of divalproex sodium in the treatment of acute mania.
    Martinez JM; Russell JM; Hirschfeld RM
    Depress Anxiety; 1998; 7(2):83-6. PubMed ID: 9614597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.